Structure Therapeutics (GPCR) Change in Acquisitions & Divestments (2022 - 2026)

Structure Therapeutics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $151.7 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 0.83% year-over-year to $151.7 million; the TTM figure through Mar 2026 stood at $631.8 million (up 36.79% YoY), while the FY2025 annual figure was $630.5 million, up 82.82% from the prior year.
• Change in Acquisitions & Divestments was $151.7 million for Q1 2026 at Structure Therapeutics, up from $146.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $195.9 million in Q3 2025 to a low of -$92.8 million in Q2 2023.
• Historically, Change in Acquisitions & Divestments has averaged $78.8 million across 5 years, with a median of $66.4 million in 2024.
• Biggest YoY gain for Change in Acquisitions & Divestments was 6954.0% in 2023; the steepest drop was 983.62% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $19.6 million in 2022, then surged by 190.82% to $57.0 million in 2023, then surged by 190.35% to $165.5 million in 2024, then retreated by 11.68% to $146.2 million in 2025, then increased by 3.79% to $151.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $151.7 million (Q1 2026), $146.2 million (Q4 2025), and $195.9 million (Q3 2025), per Business Quant data.